Effect of Statins on Platelet PAR-1 Thrombin Receptor in Patients With the Metabolic Syndrome (From the PAR-1 Inhibition by Statins [PARIS] Study)
- 1 May 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (9) , 1332-1336
- https://doi.org/10.1016/j.amjcard.2005.11.058
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injuryThrombosis and Haemostasis, 2005
- A novel mechanism of plasmin-induced mitogenesis in fibroblastsJournal of Thrombosis and Haemostasis, 2004
- Definition of Metabolic SyndromeCirculation, 2004
- Extracellular Mediators in Atherosclerosis and ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Mechanisms of Protease-activated Receptor-4 Actions in CardiomyocytesJournal of Biological Chemistry, 2003
- Proteolytically Activated Receptor-3 A Member of an Emerging Gene Family of Protease Receptors Expressed on Vascular Endothelial Cells and PlateletsTrends in Cardiovascular Medicine, 1999
- Thrombin-Induced Thromboxane Synthesis by Human PlateletsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Flow Cytometric Measurement of Platelet Function and Reticulated PlateletsAnnals of the New York Academy of Sciences, 1993
- Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion.The Journal of cell biology, 1992
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991